Article Versions Notes

Domergue C, Martin E, Lemarié C, Jézéquel P, Frenel J-S, Augereau P, Campone M, Patsouris A. Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer. Cancers. 2022; 14(10):2509. https://doi.org/10.3390/cancers14102509

Domergue, Camille, Elodie Martin, Camille Lemarié, Pascal Jézéquel, Jean-Sebastien Frenel, Paule Augereau, Mario Campone, and Anne Patsouris. 2022. "Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer" Cancers 14, no. 10: 2509. https://doi.org/10.3390/cancers14102509

Domergue, C., Martin, E., Lemarié, C., Jézéquel, P., Frenel, J.-S., Augereau, P., Campone, M., & Patsouris, A. (2022). Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer. Cancers, 14(10), 2509. https://doi.org/10.3390/cancers14102509